Please enable JavaScript to continue using this application.

Compare $AVTR vs $CRL | Chartloom

Compare

$AVTR vs $CRL

Avantor Inc · Charles River Laboratories International Inc

AVTR

Avantor Inc

CRL

Charles River Laboratories International Inc

Compare $AVTR vs $CRL

Comparing Avantor Inc and Charles River Laboratories International Inc

AVTRAvantor Inc

CRLCharles River Laboratories International Inc

AVTRAvantor Inc

Market cap

$10.60B

P/E (TTM)

—

Forward P/E (NTM)

17.83x

Forward P/S (NTM)

1.56x

Rev growth (TTM)

-1.6%

YTD performance

36.7%

52W performance

14.0%

FCF yield

4.3%

CRLCharles River Laboratories International Inc

Market cap

$14.54B

P/E (TTM)

—

Forward P/E (NTM)

24.21x

Forward P/S (NTM)

3.68x

Rev growth (TTM)

-0.7%

YTD performance

49.1%

52W performance

74.0%

FCF yield

2.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVTR

CRL

Detailed metrics comparison

AVTR

Avantor Inc

CRL

Charles River Laboratories International Inc

Market Cap

AVTR$10.60B

CRL$14.54B

Enterprise Value

AVTR$13.99B

CRL$16.97B

Price

AVTR$15.67

CRL$301.79

P/E Ratio

AVTRN/A

CRLN/A

P/S Ratio

AVTR1.62x

CRL3.64x

EV/Sales

AVTR2.13x

CRL4.24x

EV/EBITDA

AVTR15.42x

CRL19.41x

P/B Ratio

AVTR1.84x

CRL4.88x

P/FCF Ratio

AVTR23.31x

CRL39.23x

EV/FCF

AVTR30.77x

CRL45.79x

PEG Ratio

AVTRN/A

CRLN/A

Forward P/E (NTM)

AVTR17.83x

CRL24.21x

Forward P/S (NTM)

AVTR1.56x

CRL3.68x

Revenue (TTM)

AVTR$6.56B

CRL$4.00B

Revenue Growth (YoY)

AVTR-1.6%

CRL-0.7%

Forward Rev Growth

AVTR2.3%

CRL2.3%

Gross Margin (TTM)

AVTR31.8%

CRL34.6%

Operating Margin (TTM)

AVTR0.0%

CRL2.3%

EBITDA Margin (TTM)

AVTR13.8%

CRL21.6%

Net Margin (TTM)

AVTR-8.8%

CRL-6.0%

FCF Margin (TTM)

AVTR6.9%

CRL9.3%

Net Income (TTM)

AVTR$-578M

CRL$-238M

FCF (TTM)

AVTR$455M

CRL$371M

EPS (TTM)

AVTR-$0.85

CRL-$4.97

ROE (TTM)

AVTR-1034.0%

CRL-772.0%

ROA (TTM)

AVTR-495.0%

CRL-319.0%

ROIC (TTM)

AVTR-614.0%

CRL-434.0%

Cash

AVTR$307M

CRL$192M

Debt

AVTR$3.70B

CRL$2.63B

Net Cash/Debt

AVTR$-3.39B

CRL$-2.43B

Current Ratio (TTM)

AVTR1.78x

CRL1.35x

Quick Ratio (TTM)

AVTR1.18x

CRL0.83x

Debt/Equity (TTM)

AVTR0.66x

CRL0.93x

Debt/Assets (TTM)

AVTR0.0%

CRL0.0%

Interest Coverage (TTM)

AVTRN/A

CRLN/A

Net Debt/EBITDA (TTM)

AVTR0.00x

CRL0.00x

Beta

AVTR0.98

CRL1.38

52W Performance

AVTR14.0%

CRL74.0%

YTD Performance

AVTR36.7%

CRL49.1%

% from 52W High

AVTR-4.3%

CRL-9.5%

% from 52W Low

AVTR115.7%

CRL106.4%

Asset Turnover (TTM)

AVTR0.56x

CRL0.53x

FCF Yield (TTM)

AVTR4.3%

CRL2.5%

Earnings Yield (TTM)

AVTR-5.5%

CRL-1.6%

Dividend Yield (TTM)

AVTRN/A

CRLN/A

Rule of 40

AVTR5.4

CRL8.5

EV/GP/RG

AVTR1.90

CRL5.20

Ticker research

View AVTR research View CRL research

Metric	AVTR Avantor Inc	CRL Charles River Laboratories International Inc
Market & Valuation
Market Cap	$10.60B	$14.54B
Enterprise Value	$13.99B	$16.97B
Price	$15.67	$301.79
P/E Ratio	N/A	N/A
P/S Ratio	1.62x	3.64x
EV/Sales	2.13x	4.24x
EV/EBITDA	15.42x	19.41x
P/B Ratio	1.84x	4.88x
P/FCF Ratio	23.31x	39.23x
EV/FCF	30.77x	45.79x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	17.83x	24.21x
Forward P/S (NTM)	1.56x	3.68x
Revenue & Growth
Revenue (TTM)	$6.56B	$4.00B
Revenue Growth (YoY)	-1.6%	-0.7%
Forward Rev Growth	2.3%	2.3%
Profitability
Gross Margin (TTM)	31.8%	34.6%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	13.8%	21.6%
Net Margin (TTM)	-8.8%	-6.0%
FCF Margin (TTM)	6.9%	9.3%
Net Income (TTM)	$-578M	$-238M
FCF (TTM)	$455M	$371M
EPS (TTM)	-$0.85	-$4.97
ROE (TTM)	-1034.0%	-772.0%
ROA (TTM)	-495.0%	-319.0%
ROIC (TTM)	-614.0%	-434.0%
Financial Health
Cash	$307M	$192M
Debt	$3.70B	$2.63B
Net Cash/Debt	$-3.39B	$-2.43B
Current Ratio (TTM)	1.78x	1.35x
Quick Ratio (TTM)	1.18x	0.83x
Debt/Equity (TTM)	0.66x	0.93x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	1.38
52W Performance	14.0%	74.0%
YTD Performance	36.7%	49.1%
% from 52W High	-4.3%	-9.5%
% from 52W Low	115.7%	106.4%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.53x
FCF Yield (TTM)	4.3%	2.5%
Earnings Yield (TTM)	-5.5%	-1.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	8.5
EV/GP/RG	1.90	5.20
Ticker research	View AVTR research	View CRL research

Valuation

P/S Ratio

AVTR

1.62x

CRL

3.64x

EV/FCF

AVTR

30.77x

CRL

45.79x

Growth & revenue

Revenue Growth TTM

CRL

-0.7%

AVTR

-1.6%

Forward Revenue Growth

CRL

2.3%

AVTR

2.3%

Profitability & performance

Gross Margin

CRL

34.6%

AVTR

31.8%

ROE

CRL

-772.0%

AVTR

-1034.0%

FCF Yield %

AVTR

4.3%

CRL

2.5%

52-Week Performance

CRL

74.0%

AVTR

14.0%

Detailed metrics comparison

AVTR

Avantor Inc

CRL

Charles River Laboratories International Inc

Market Cap

AVTR$10.60B

CRL$14.54B

Enterprise Value

AVTR$13.99B

CRL$16.97B

Price

AVTR$15.67

CRL$301.79

P/E Ratio

AVTRN/A

CRLN/A

P/S Ratio

AVTR1.62x

CRL3.64x

EV/Sales

AVTR2.13x

CRL4.24x

EV/EBITDA

AVTR15.42x

CRL19.41x

P/B Ratio

AVTR1.84x

CRL4.88x

P/FCF Ratio

AVTR23.31x

CRL39.23x

EV/FCF

AVTR30.77x

CRL45.79x

PEG Ratio

AVTRN/A

CRLN/A

Forward P/E (NTM)

AVTR17.83x

CRL24.21x

Forward P/S (NTM)

AVTR1.56x

CRL3.68x

Revenue (TTM)

AVTR$6.56B

CRL$4.00B

Revenue Growth (YoY)

AVTR-1.6%

CRL-0.7%

Forward Rev Growth

AVTR2.3%

CRL2.3%

Gross Margin (TTM)

AVTR31.8%

CRL34.6%

Operating Margin (TTM)

AVTR0.0%

CRL2.3%

EBITDA Margin (TTM)

AVTR13.8%

CRL21.6%

Net Margin (TTM)

AVTR-8.8%

CRL-6.0%

FCF Margin (TTM)

AVTR6.9%

CRL9.3%

Net Income (TTM)

AVTR$-578M

CRL$-238M

FCF (TTM)

AVTR$455M

CRL$371M

EPS (TTM)

AVTR-$0.85

CRL-$4.97

ROE (TTM)

AVTR-1034.0%

CRL-772.0%

ROA (TTM)

AVTR-495.0%

CRL-319.0%

ROIC (TTM)

AVTR-614.0%

CRL-434.0%

Cash

AVTR$307M

CRL$192M

Debt

AVTR$3.70B

CRL$2.63B

Net Cash/Debt

AVTR$-3.39B

CRL$-2.43B

Current Ratio (TTM)

AVTR1.78x

CRL1.35x

Quick Ratio (TTM)

AVTR1.18x

CRL0.83x

Debt/Equity (TTM)

AVTR0.66x

CRL0.93x

Debt/Assets (TTM)

AVTR0.0%

CRL0.0%

Interest Coverage (TTM)

AVTRN/A

CRLN/A

Net Debt/EBITDA (TTM)

AVTR0.00x

CRL0.00x

Beta

AVTR0.98

CRL1.38

52W Performance

AVTR14.0%

CRL74.0%

YTD Performance

AVTR36.7%

CRL49.1%

% from 52W High

AVTR-4.3%

CRL-9.5%

% from 52W Low

AVTR115.7%

CRL106.4%

Asset Turnover (TTM)

AVTR0.56x

CRL0.53x

FCF Yield (TTM)

AVTR4.3%

CRL2.5%

Earnings Yield (TTM)

AVTR-5.5%

CRL-1.6%

Dividend Yield (TTM)

AVTRN/A

CRLN/A

Rule of 40

AVTR5.4

CRL8.5

EV/GP/RG

AVTR1.90

CRL5.20

Ticker research

View AVTR research View CRL research

Metric	AVTR Avantor Inc	CRL Charles River Laboratories International Inc
Market & Valuation
Market Cap	$10.60B	$14.54B
Enterprise Value	$13.99B	$16.97B
Price	$15.67	$301.79
P/E Ratio	N/A	N/A
P/S Ratio	1.62x	3.64x
EV/Sales	2.13x	4.24x
EV/EBITDA	15.42x	19.41x
P/B Ratio	1.84x	4.88x
P/FCF Ratio	23.31x	39.23x
EV/FCF	30.77x	45.79x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	17.83x	24.21x
Forward P/S (NTM)	1.56x	3.68x
Revenue & Growth
Revenue (TTM)	$6.56B	$4.00B
Revenue Growth (YoY)	-1.6%	-0.7%
Forward Rev Growth	2.3%	2.3%
Profitability
Gross Margin (TTM)	31.8%	34.6%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	13.8%	21.6%
Net Margin (TTM)	-8.8%	-6.0%
FCF Margin (TTM)	6.9%	9.3%
Net Income (TTM)	$-578M	$-238M
FCF (TTM)	$455M	$371M
EPS (TTM)	-$0.85	-$4.97
ROE (TTM)	-1034.0%	-772.0%
ROA (TTM)	-495.0%	-319.0%
ROIC (TTM)	-614.0%	-434.0%
Financial Health
Cash	$307M	$192M
Debt	$3.70B	$2.63B
Net Cash/Debt	$-3.39B	$-2.43B
Current Ratio (TTM)	1.78x	1.35x
Quick Ratio (TTM)	1.18x	0.83x
Debt/Equity (TTM)	0.66x	0.93x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	1.38
52W Performance	14.0%	74.0%
YTD Performance	36.7%	49.1%
% from 52W High	-4.3%	-9.5%
% from 52W Low	115.7%	106.4%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.53x
FCF Yield (TTM)	4.3%	2.5%
Earnings Yield (TTM)	-5.5%	-1.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	8.5
EV/GP/RG	1.90	5.20
Ticker research	View AVTR research	View CRL research